Feedback / Questions
ADI-001 - Adicet Bio
https://www.businesswire.com/news/home/20241016854445/en/Adicet-Bio-Announces-FDA-Clearance-of-IND-Amendment-to-Evaluate-ADI-001-in-Idiopathic-Inflammatory-Myopathy-and-Stiff-Person-Syndrome
Oct 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next